Stryker Corp

SYK

358.290USD

-4.120-1.14%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

Stryker Corp's Score

Industry at a Glance

Industry Ranking

33 / 205

Overall Ranking

120 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Stryker Corp Highlights

StrengthsRisks

Stryker Corporation is a medical technology company. The Company offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The Company also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 22.53% year-on-year.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 41.30%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 41.30%.

Fairly Valued

The company’s latest PE is 42.19, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 314.74M shares, decreasing 1.09% quarter-over-quarter.

Held by Brandes Investmen

Star Investor Brandes Investmen holds 447.00 shares of this stock.

Analyst Rating

Based on 32 analysts

Buy

Current Rating

424.665

Target Price

+17.75%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current financial score of Stryker Corp is 8.70, ranking 32 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 7.17B, representing a year-over-year increase of 11.42%, while its net profit experienced a year-over-year increase of 55.49%.

Score

Industry at a Glance

Previous score

8.70

Change

0



Financials

7.19

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

8.78

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

9.62

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

8.75

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

9.17

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

The current valuation score of Stryker Corp is 6.29, ranking 166 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 42.19, which is 25.12% below the recent high of 52.78 and 17.42% above the recent low of 34.84.

Score

Industry at a Glance

Previous score

6.29

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 33/205

Relevant data have not been disclosed by the company yet.

The current earnings forecast score of Stryker Corp is 8.13, ranking 57 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 435.00, with a high of 465.00 and a low of 317.70.

Score

Industry at a Glance

Previous score

8.13

Change

0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current price momentum score of Stryker Corp is 6.62, ranking 114 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 372.80 and the support level at 346.90, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.89

Change

-0.27

Support & Resistance

Relevant data have not been disclosed by the company yet.

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Stryker Corp is 7.00, ranking 80 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 82.30%, representing a quarter-over-quarter increase of 1.01%. The largest institutional shareholder is The Vanguard, holding a total of 33.74M shares, representing 8.82% of shares outstanding, with 2.47% increase in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

33.62M

+0.80%

Brown (John W)

20.06M

--

Greenleaf Trust

16.64M

-0.27%

BlackRock Institutional Trust Company, N.A.

16.26M

+1.13%

State Street Investment Management (US)

14.94M

-0.09%

T. Rowe Price Associates, Inc.

Star Investors

10.48M

-7.98%

Geode Capital Management, L.L.C.

7.47M

+0.98%

JP Morgan Asset Management

7.14M

-3.15%

AllianceBernstein L.P.

6.34M

+13.25%

Capital Research Global Investors

6.27M

-7.28%



1

2



The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Stryker Corp is 9.56, ranking 6 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.87. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.

Stryker Corp

SYK

7.72 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

LivaNova PLC

LIVN

8.61 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Cencora Inc

COR

8.47 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Becton Dickinson and Co

BDX

8.46 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

AxoGen Inc

AXGN

8.42 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Align Technology Inc

ALGN

8.42 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment